{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:57:03Z","timestamp":1789199823418,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20CIII\/00038"],"award-info":[{"award-number":["PI20CIII\/00038"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23CIII\/00041"],"award-info":[{"award-number":["PI23CIII\/00041"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00094"],"award-info":[{"award-number":["PI21\/00094"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020419","name":"Cure CMD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2025.201653","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:44:44Z","timestamp":1766767484000},"page":"201653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CRISPR-mediated targeting of the LMNA c.745C>T mutation enhances survival and cardiac function in congenital muscular dystrophy"],"prefix":"10.1016","volume":"34","author":[{"given":"D\u00e9borah","family":"G\u00f3mez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Epifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Vilaplana-Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Amarilla-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Cesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"de Molina-Iracheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sarquella-Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"P\u00e9rez de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2025.201653_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.21417","article-title":"De novo LMNA mutations cause a new form of congenital muscular dystrophy","volume":"64","author":"Quijano-Roy","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omta.2025.201653_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2013.11.010","article-title":"Congenital muscular dystrophy with dropped head linked to the LMNA gene in a Brazilian cohort","volume":"50","author":"Pasqualin","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.omta.2025.201653_bib3","article-title":"Phenotype-Genotype Analysis of Chinese Patients with Early-Onset LMNA-Related Muscular Dystrophy","volume":"10","author":"Tan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201653_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejpn.2021.04.005","article-title":"Floppy infant syndrome as a first manifestation of LMNA-related congenital muscular dystrophy","volume":"32","author":"J\u0119drzejowska","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omta.2025.201653_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab075","article-title":"International retrospective natural history study of LMNA-related congenital muscular dystrophy","volume":"3","author":"Ben Yaou","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.omta.2025.201653_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-pathol-042220-034240","article-title":"Molecular Pathology of Laminopathies","volume":"17","author":"Shin","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omta.2025.201653_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cells9040844","article-title":"Lamin A\/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery-Dreifuss Muscular Dystrophy","volume":"9","author":"Bertrand","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omta.2025.201653_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1135438","article-title":"LMNA-related muscular dystrophy: Identification of variants in alternative genes and personalized clinical translation","volume":"14","author":"Cesar","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.omta.2025.201653_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jmedgenet-2019-106671","article-title":"Clinical spectrum and genetic variations of LMNA-related muscular dystrophies in a large cohort of Chinese patients Genotype-phenotype correlations","volume":"58","author":"Fan","year":"2021","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omta.2025.201653_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1142937","article-title":"Characterization of cardiac involvement in children with LMNA-related muscular dystrophy","volume":"11","author":"Cesar","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omta.2025.201653_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/21678707.2016.1180975","article-title":"Clinical features and therapeutic strategies for managing the striated muscle laminopathies","volume":"4","author":"Macquart","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omta.2025.201653_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13457","article-title":"Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome","volume":"20","author":"Cabral","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.omta.2025.201653_bib13","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41467-018-03770-3","article-title":"Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome","volume":"9","author":"Balmus","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2025.201653_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2044-5040-3-17","article-title":"Inhibition of extracellular signal-regulated kinase 1\/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A\/C gene mutation","volume":"3","author":"Muchir","year":"2013","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omta.2025.201653_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","article-title":"Single-dose CRISPR\u2013Cas9 therapy extends lifespan of mice with Hutchinson\u2013Gilford progeria syndrome","volume":"25","author":"Beyret","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2025.201653_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41591-018-0338-6","article-title":"Development of a CRISPR\/Cas9-based therapy for Hutchinson\u2013Gilford progeria syndrome","volume":"25","author":"Santiago-Fern\u00e1ndez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2025.201653_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omta.2025.201653_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13388","article-title":"Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS","volume":"20","author":"Gete","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.omta.2025.201653_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30800-y","article-title":"Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice","volume":"13","author":"Whisenant","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2025.201653_bib20","article-title":"LMNA Co-Regulated Gene Expression as a Suitable Readout after Precise Gene Correction","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2025.201653_bib21","doi-asserted-by":"crossref","DOI":"10.1063\/5.0244026","article-title":"Adenine base editing rescues pathogenic phenotypes in tissue engineered vascular model of Hutchinson-Gilford progeria syndrome","volume":"9","author":"Abutaleb","year":"2025","journal-title":"APL Bioeng."},{"key":"10.1016\/j.omta.2025.201653_bib22","article-title":"Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C > T mutation in murine hearts","volume":"28","author":"Yang","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.omta.2025.201653_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2515267122","article-title":"Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease","volume":"122","author":"Caravia","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201653_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtn.2017.12.012","article-title":"Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy","volume":"10","author":"Azibani","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2025.201653_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2025.201653_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2025.201653_bib27","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1093\/nar\/gkv892","article-title":"Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage","volume":"43","author":"Josephs","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2025.201653_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fphys.2018.01332","article-title":"Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations","volume":"9","author":"Steele-Stallard","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omta.2025.201653_bib29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.147.5.913","article-title":"Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy","volume":"147","author":"Sullivan","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2025.201653_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/hum.2016.009","article-title":"CRISPRs for optimal targeting: Delivery of CRISPR components as DNA, RNA, and protein into cultured cells and single-cell embryos","volume":"27","author":"Kouranova","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2025.201653_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cbpa.2015.10.001","article-title":"How specific is CRISPR\/Cas9 really?","volume":"29","author":"O\u2019Geen","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.omta.2025.201653_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex Genome Engineering Using CRISPR\/Cas Systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omta.2025.201653_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2025.201653_bib34","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1073\/pnas.1104144108","article-title":"Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence","volume":"108","author":"Semenova","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201653_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12778","article-title":"Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9","volume":"7","author":"Singh","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2025.201653_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nbt.2889","article-title":"Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells","volume":"32","author":"Wu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2025.201653_bib37","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omta.2025.201653_bib38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.celrep.2014.09.044","article-title":"Enhanced specificity and efficiency of the CRISPR\/Cas9 system with optimized sgRNA parameters in Drosophila","volume":"9","author":"Ren","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2025.201653_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/cells9020310","article-title":"Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls","volume":"9","author":"Desgrouas","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omta.2025.201653_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051286","article-title":"Consequences of lmna exon 4 mutations in myoblast function","volume":"9","author":"G\u00f3mez-Dom\u00ednguez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omta.2025.201653_bib41","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1242\/jcs.114.24.4447","article-title":"Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy","volume":"114","author":"Raharjo","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omta.2025.201653_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2025.201653_bib43","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of Cell Generation and Turnover in the Human Heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omta.2025.201653_bib44","first-page":"41","article-title":"Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution","volume":"28","author":"Nag","year":"1980","journal-title":"Cytobios"},{"key":"10.1016\/j.omta.2025.201653_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CrIsPr-Cas nuclease specificity using truncated guide rNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2025.201653_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226107","article-title":"Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR\/Cas9 gene editing system","volume":"14","author":"Matson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201653_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2025.201653_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omta.2025.201653_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.omtn.2022.03.004","article-title":"Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice","volume":"28","author":"Karri","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2025.201653_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omta.2025.201653_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.omtn.2022.07.024","article-title":"A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing","volume":"29","author":"Zhang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2025.201653_bib52","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2025.201653_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002847","article-title":"Splicing-directed therapy in a new mouse model of human accelerated aging","volume":"3","author":"Osorio","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2025.201653_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gt.2015.8","article-title":"Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies","volume":"22","author":"Scharner","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2025.201653_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.12.e132","article-title":"Mutation analysis of the lamin A\/C gene (LMNA) among patients with different cardiomuscular phenotypes","volume":"40","author":"Vytopil","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omta.2025.201653_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-9167-9_7","article-title":"Chapter 7 Generation and Culture of Mouse Embryonic Fibroblasts","volume":"1960","author":"Tan","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2025.201653_bib57","doi-asserted-by":"crossref","first-page":"W267","DOI":"10.1093\/nar\/gkw407","article-title":"Breaking-Cas\u2014interactive design of guide RNAs for CRISPR-Cas experiments for ENSEMBL genomes","volume":"44","author":"Oliveros","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2025.201653_bib58","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omta.2025.201653_bib59","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ymthe.2020.06.021","article-title":"Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice","volume":"28","author":"Lahey","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2025.201653_bib60","article-title":"Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts","volume":"2016","author":"Ding","year":"2016","journal-title":"J. Vis. Exp."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:34:38Z","timestamp":1783028078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X25000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X25000035"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2025.201653","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-mediated targeting of the LMNA c.745C>T mutation enhances survival and cardiac function in congenital muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2025.201653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201653"}}